Resources

Commissioner

NHS England, CCGs and local authorities are all responsible for commissioning different parts of hepatitis C testing, treatment and care.  Find here tools, templates and other relevant documents to assist commissioners with their responsibilities to ensure hepatitis C patients are diagnosed and receive high quality care.

Showing 201 to 210 of 226 resources

  • Blood Borne Viral Hepatitis Action Plan for Wales 2010-2015
    This document sets out the WAG blood borne viral hepatitis action plan for Wales for the period April 2010 - April 2015. It is proposed that during this period, services in Wales will be continually re-evaluated and markers of success (reduction in transmission rates and significant increases in numbers diagnosed and treated) and barriers to progress identified. Further action to tackle chronic HBV and HCV in Wales will be identified for action from 2015. This action plan aims to provide a clear, costed and time defined framework for the planning and provision of key services in Wales.
    Wales Feb 2010 Reports & Research PDF
  • Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis
    This systematic literature review seeks to determine whether tattooing is a risk factor for the transmission of hepatitis C. A comprehensive search was performed to identify all case-control, cohort or cross sectional studies published prior to November 2008 that evaluated risks related to tattooing or risk factors of transmission of hepatitis C infection. A total of 124 studies were included in this systematic review, of which 83 were included in themeta-analysis.
    UK, Rest of World 2010 Reports & Research PDF
  • Characteristics of an ideal Hepatitis C service - summary paper
    In this paper Siobhan Fahey, the Greater Manchester Programme lead for Hepatitis C, and Julie Cunningham, commissioning manager within the Commissioning Business Service (CBS), review the processes undertaken in engaging with stakeholder groups during the Greater Manchester HCV strategy. Stakeholder groups were given the opportunity to comment on what they thought were the key characteristics of an ideal Hepatitis C service in relation to the various parts of the care pathway.
    North West Jan 2010 Case study, Reports & Research, Tools & Templates, Strategy & Planning PDF
  • The NHS Outcomes Framework 2011/12
    The Government’s plans for reform across the NHS, public health and adult social care are designed to enable services to deliver improved outcomes. The cornerstone will be a framework of accountability that focuses squarely on how well services are improving outcomes for people. For the NHS, this begins with accountability at a national level focused on health outcomes. An NHS Outcomes Framework was developed to provide national level accountability for the outcomes that the NHS delivers. This document sets out the first NHS Outcomes Framework.
    England 2010 Reports & Research PDF
  • Greater Manchester Hepatitis C Self Support Project: May 2010 - April 2013
    The following document presents a plan for a Greater Manchester Hepatitis C Strategy project providing client centred, self-care support to people with Hepatitis C in Greater Manchester. The project was funded for 3 years and aimed to provide a sustainable system for self-care support to be in place across the whole of Greater Manchester. The Project aimed to work closely with existing Hepatitis C Support groups to ensure their sustainability. It also aimed to work with people with Hepatitis C to ensure that Hepatitis C Support Groups are
    North West 2010 Case study, Tools & Templates PDF
  • Diagnosing viral hepatitis in the community: A 3-month pharmacy testing pilot
    This document sets out the findings of a 3 month pharmacy testing pilot.
    England Jan 2010 Case study, Reports & Research PDF
  • Hepatitis C: Increasing Awareness and Improving Access to Testing for the South Asian Community in Bedford
    In the United Kingdom (UK), the majority of individuals infected with Hepatitis C are past or present injecting drug users. However, there is a higher than average HCV prevalence among the South Asian community compared with the general population in the UK. For instance, the Pakistani community has been noted as having a greater than 2% prevalence of HCV, despite the majority of them never having injected drugs.
    East of England 2010 Reports & Research PDF
  • Hepatitis C: Increasing Awareness and Improving Access to Testing for the South Asian Community in Bedford
    In the United Kingdom (UK), the majority of individuals infected with Hepatitis C are past or present injecting drug users. However, there is a higher than average HCV prevalence among the South Asian community compared with the general population in the UK. For instance, the Pakistani community has been noted as having a greater than 2% prevalence of HCV, despite the majority of them never having injected drugs.
    East of England 2010 Reports & Research PDF
  • Hepatitis C: Out of control. An audit of Strategic Health Authority hepatitis c governance
    In 2004 the Department of Health published the Hepatitis C Action Plan for England, which set out actions on surveillance, research, increasing awareness and prevention and improving service quality for patients. However, there is concern, most recently expressed by the All Party Parliamentary Hepatology Group in its report, Divided Nations: Tackling the hepatitis C challenge across the UK, that there is a lack of implementation of the Action Plan because of poor governance arrangements, monitoring and evaluation1.
    England 16 Jul 2009 Reports & Research PDF
  • East Midlands Specialised Commissioning Group Commissioning Policy for Hepatitis C Treatments
    This commissioning policy paper was produced for the treatment of patients with Hepatitis C in the East Midlands, with the aim of providing and ensuring equity, consistency and clarity in approach to treatment across the region. The document sets out the position of East Midlands Specialised Commissioning Group PCTs in respect of treatment for Hepatitis C for its current and future patients, outlining the treatment regimens for the various different genotypes of Hepatitis C using combination therapy (pegylated interferon alpha and weight-based ribavirin).
    East Midlands Jun 2009 Case study, Tools & Templates, Strategy & Planning PDF

Pages